HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Next-Gen Robotic Exoscope Delivers Leap Forward in Optical Performance to Modernize ORs

By HospiMedica International staff writers
Posted on 24 Mar 2023
Image: Modus X enables better ergonomics, offering a pain-free operative experience (Photo courtesy of Synaptive Medical)
Image: Modus X enables better ergonomics, offering a pain-free operative experience (Photo courtesy of Synaptive Medical)

The next-generation model of a robotic exoscope, which has undergone extensive clinical validation through thousands of surgical procedures, now offers advanced 4K 3D optics and fluorescence modalities to augment surgical visualization in neurosurgery, ENT, plastics, and the spine.

Modus X is the fourth generation of robotic exoscope from Synaptive Medical Inc. (Toronto, Canada) that allows surgeons to undertake minimally invasive approaches and provides improved ergonomics for a pain-free operative experience. Modus X is part of integrated suite of products from Synaptive that connect clinicians in operating rooms across mid-field MRI, surgical planning and navigation, and surgical visualization. Synaptive’s devices automate critical patient data through each step of surgical intervention to enhance clinical decision-making.

The next-generation Modus X from Synaptive features redesigned 4K 3D optics, 27x magnification, automated image focus, and voice guidance, marking a leap forward in optical performance and robotics to modernize operating rooms. The unique platform allows for fluorescence-guided surgery in order to improve oncological tissue differentiation in real time. The Modus X also features a flexible design to enable field upgrades of Modus V, Synaptive’s third-generation exoscope, which has been installed in 80 hospitals globally. Synaptive has announced the FDA registration for its fourth-generation robotic exoscope, Modus X, making it available in the U.S. and Canada.

“We anticipate these enhanced visualization capabilities will enable surgeons to perform even more effective and precise interventions to the benefit of their patients,” said Cameron Piron, President, and Co-founder of Synaptive Medical. “Through years of interdisciplinary collaboration with our clinical partners, we have arrived at this ultimate platform that pushes the boundaries of surgical visualization.”

Related Links:
Synaptive Medical Inc.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more